Tech Company Financing Transactions
VectorBuilder Funding Round
Legend Capital and private investors participated in a $57 million Series C capital raise for VectorBuilder. The round was announced on 10/20/2022.
Transaction Overview
Company Name
Announced On
10/20/2022
Transaction Type
Venture Equity
Amount
$57,000,000
Round
Series C
Investors
Legend Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to promote the upgrading and capacity expansion of the gene delivery R&D and production technology platform, further accelerate the global business presence, and boost the R&D of life sciences and genetic medicines.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1010 W 35th St. 515
Chicago, IL 60609
USA
Chicago, IL 60609
USA
Phone
Website
Email Address
Overview
VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Bruce Lahn
Browse more venture capital transactions:
Prev: 10/20/2022: Tensorleap venture capital transaction
Next: 10/20/2022: Limit venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs